Colivelin TFA is a neuroprotective peptide that can cross the blood–brain barrier (38) and, therefore, interact with leptin-STAT3 signaling in the central nervous system to promote diabetes and DCM. This evidence concerns the gene STAT3 and diabetes mellitus.